ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,976Top JournalHybrid

Biochemical Pharmacology

Acronym:bp
•
Abbreviation (ISO):BIOCHEM. PHARMACOL
•
Identifier (ISSN):0006-2952(Print)/1873-2968(Online)
•
Publisher:Elsevier Inc.
Clarivate IF (2026)
6.5↑ +0.9
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Biochemical Pharmacology

WoS Q1
24794.2420184.8320194.9620205.8620216.120225.820235.320245.620256.52026
Annual Impact Factor Metric
Current (2026):6.5
Scopus SJR & RankScopus Q1
1.687
#1,976

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
234

234 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
422articles/year
22.66% Gold OA•64.94% Original Research

Aims & Scope

Biochemical Pharmacology publishes original research findings, Commentaries and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics. The journal's target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process. All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complimentary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review. While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.

Topics Covered (Recognized by AI)
Chemistry96.2%Biology95.9%Biochemistry90.6%Medicine88%Genetics81.1%Internal medicine80.9%Organic chemistry65.4%Endocrinology60.5%Physics57%Nuclear magnetic resonance51.8%Enzyme50.4%Pharmacology41.1%In vitro30.9%Gene27.8%Cell biology27.8%Psychology27.4%Receptor27.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank41/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank50/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF6.5
Articles / Year730
Total Citations521
2025
IF5.6
Articles / Year785
Total Citations3,106
2024
IF5.3
Articles / Year603
Total Citations6,667
2023
IF5.8
Articles / Year505
Total Citations9,631
2022
IF6.1
Articles / Year403
Total Citations10,511

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,976Scopus Q1SCImago Profile
Scopus Coverage:1958-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.687

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.52

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,563 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations9,532
3-Year Documents1,425
Citable Documents1,412

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ1
PharmacologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Biochemical Pharmacology (acronym: bp, abbr: BIOCHEM. PHARMACOL, ISSN: 0006-2952) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Inc. in United States since 1958. The periodical holds a Journal Impact Factor (JIF) of 6.50, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.687 (Q1), an H-index of 234.

The journal enforces rigorous peer evaluation with an average review speed of 3.3周, a publication frequency of Semimonthly, an annual output of approximately 422 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,563 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Inc.
Publication Language
English
Frequency
Semimonthly
Founding Year
1958
Indexing & Databases
SCIEScopusPubMed
Editorial Address
PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f2b59eff-a795-482a-9052-a6bf83420773
Database Updated: 2026-09-28